Structural, thermodynamic, and kinetic aspects of the trimorphism of hydrocortisone

Journal of Pharmaceutical Sciences

Volumn 97, Issue 10, 2008, Pages 4516-4527

  Suitchmezian, Viktor ^a   Jeß, Inke ^a   Näther, Christian ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Calorimetry (DSC); Cocrystals; Crystal structure; Crystals; Desolvation; Hydrocortisone; Polymorphism; Pseudopolymorphism; Thermogravimetric analysis; X ray powder diffractometry

Indexed keywords

HYDROCORTISONE;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG TRANSFORMATION; HYDROGEN BOND; KINETICS; SOLVATION; THERMODYNAMICS;

EID: 55749084374     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21334     Document Type: Article

References (20)

1. Brittain HG. 1999. Polymorphism in pharmaceutical solids. Vol. 95, New York: Marcel Dekker Inc, pp. 1-124.
2. Vippagunta SR, Brittain HG, Grant DJW. 2001. Crystalline solids. Adv Drug Deliv Rev 48:3-26.
3. DeCamp WH. 2000. The impact of polymorphism on drug development: A regulators viewpoint. Am Pharm Rev 3:70-77.
4. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. 2001. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev 48:91-114.
5. Allen FH. 2002. The Cambridge Structural Database: A quarter of a million crystal structures and rising. Acta Cryst B58:380-388. Version 5.27., 2007.
6. Näther C, Jeß I. 2006. News from an old drug: Investigations on the polymorphism of triamcinolone acetonide. Angew Chem Int Ed 45:6381-6383.
7. Suitchmezian V, Jeß I, Näther C. 2006. Investigations on the polymorphism and pseudopolymorphism of triamcinolone diacetate. Int J Pharm 323:101-109.
8. Suitchmezian V, Jeß I, Näther C. 2007. Investigations on the polymorphism and pseudopolymorphism of the glucocorticoid triamcinolone. New findings for a well-known drug. Cryst Growth Des 7:69-74.
9. Florey K. 1983. Hydrocortisone. In: Florey K, editor. Analytical profiles of drug substances, Vol. 12. New York: Academic Press, pp. 277-324 and literature cited therein.
10. Kuhnert-Brandstätter M, Gasser P. 1971. Solvates and polymorphic modifications of steroid hormones II. Mikrochem J 16:577-589.
11. Mesley RJ. 1966. The infra-red spectra of steroids in the solid state. Spectrochim Acta 22: 889-917.
12. Haner BA, Norton DA. 1964. Crystal data (I) for some pregnenes and pregnadienes. Acta Crystallogr 17:1610.
13. 5N. Acta Crystallogr B30:90-94.
14. Roberts PJ, Coppola JC, Isaacs NW, Kennard O. 1973. Crystal and molecular structure of cortisol (11β,17α,21-trihydroxypregn-4-ene-3,20-dione) methanol solvate. J Chem Soc Perkin Trans II 6:774-781.
15. Chen J, Wang J, Zhang Y, Wu H, Chen W, Guo Z. 2004. Crystal growth, structure and morphology of hydrocortisone methanol solvate. J Cryst Growth 265:266-273.
16. Castellano EE, Main P, Westbrook E. 1980. The disordered structure of cortisol (11∼,17∼,21-tlqhydroxy-4-pregnene-3,20-dione) and iodoeortisol (1 lp, l 7∼-dihydroxy-2 l-iodo-4-pregnene-3,20-dione). Acta Crystallogr B36:3063-3067.
17. Petropavlov NN, Kostin NF, Ermarkova GA, Shemeryankin BV, Messinova OV, Rattel NN. 1975. Polymorphism of hydrocortisone. Pharm Chem 7:459-461.
18. Etter C, MacDonald J, Bernstein J. 1990. Graph-set analysis of hydrogen-bond patterns in organic crystals. Acta Crystallogr B46:256-262.
19. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. Mikrochim Acta 2:259-271.
20. Grunenberg A, Henck JO, Siesler HW. 1996. Theoretical derivation and practical application of energy/temperature diagrams as an instrument in preformulation studies of polymorphic drug substances. Int J Pharm 129:147-158.